39.15 Exc
Apply diluted in a carrier oil to the scalp 2-3 times weekly
SN-38 has been linked to two different mAbs, the resultant ADCs are both in phase 2 clinical trials: IMMU-130 (labetuzumab-SN38, anti-CEACAM5) is being tested in colorectal cancer (CRC) and IMMU-132 (anti-TROP-2) is being pursued in solid tumors (21, 22)
Seek immediate medical attention if any of these rare but very serious symptoms occur: chest pain (especially with shortness of breath), weakness on one side of the body, sudden vision changes, slurred speech
MitoCOREsupplies key mitochondrial micronutrients and a smart combination of alpha lipoic acid, N-acetyl cysteine, and acetyl L-carnitine to boost cellular energy production
To view a copy of this licence, visit About this article Cite this article Bell, C.J.M., Mehta, M., Mirza, L